Role of Circular RNAs in Cardiovascular Disease
Overview
Affiliations
Circular RNAs (circRNAs) have recently been identified as a new class of long noncoding RNAs with gene regulatory roles. These covalently closed transcripts are generated when the pre-mRNA splicing machinery back splices to join a downstream 5' splice site to an upstream 3' splice site. CircRNAs are naturally resistant to degradation by exonucleases and have long half-lives compared with their linear counterpart that potentially could serve as biomarkers for disease. Recent evidence highlights that circRNAs may play an essential role in cardiovascular injury and repair. However, our knowledge of circRNA is still in its infancy with limited direct evidence to suggest that circRNA may play critical roles in the mechanism and treatment of cardiac dysfunction. In this review, we focus on our current understanding of circRNA in the cardiovascular system.
Fan Z, Yuan X, Yuan Y Int J Mol Med. 2024; 55(1).
PMID: 39513584 PMC: 11573316. DOI: 10.3892/ijmm.2024.5452.
Cardiomyopathies: The Role of Non-Coding RNAs.
Carabetta N, Siracusa C, Leo I, Panuccio G, Strangio A, Sabatino J Noncoding RNA. 2024; 10(6).
PMID: 39449507 PMC: 11503404. DOI: 10.3390/ncrna10060053.
Identification of circular RNAs regulating cardiomyocyte proliferation in neonatal pig hearts.
Tang L, Nyarige V, Li P, Wang J, Zhu W JCI Insight. 2024; 9(15).
PMID: 38916964 PMC: 11383601. DOI: 10.1172/jci.insight.175625.
Circular RNAs in Cardiovascular Diseases: Regulation and Therapeutic Applications.
Wang L, Xu G, Spanos M, Li G, Lei Z, Sluijter J Research (Wash D C). 2023; 6:0038.
PMID: 37040523 PMC: 10076034. DOI: 10.34133/research.0038.
The Landscape of Circular RNAs in Cardiovascular Diseases.
Long Q, Lv B, Jiang S, Lin J Int J Mol Sci. 2023; 24(5).
PMID: 36902000 PMC: 10003248. DOI: 10.3390/ijms24054571.